Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Stem-Cell Scientist Linked With Retracted Studies Dies

Don't Miss Out —
Follow us on:
Yoshiki Sasai
A file photo from April 16, 2014 shows Yoshiki Sasai, deputy director of Riken’s Center for Developmental Biology, answering questions during a news conference in Tokyo. Photographer: Toru Yamanaka/AFP/Getty Images

Aug. 5 (Bloomberg) -- A prominent Japanese scientist who was a co-author on stem-cell research that was retracted last month died today in the city of Kobe, local police said.

Yoshiki Sasai, deputy director of Riken’s Center for Developmental Biology, was found hanging at the center and his death was confirmed at 11:03 a.m. at a hospital, according to a spokesman for the Hyogo Prefectural Police who asked not to be identified because of the agency’s rules. Sasai left an apparent suicide note on the desk of his secretary, Jun Nonaka, a spokesman at Riken, said by telephone today.

Sasai was one of the co-authors of a pair of stem cell studies published in the journal Nature in January that outlined a simpler, quicker way to make stem cells. In July, Nature confirmed the retraction of the two studies, which had said ordinary cells taken from newborn mice could be transformed into stem cells without adding genes.

The studies, led by Haruko Obokata at Riken, were retracted after an investigation by the research center showed she falsified some data and was solely responsible for the misconduct. Co-authors Teruhiko Wakayama at University of Yamanashi and Sasai at Riken bear “heavy responsibility” for allowing the papers to be submitted to the journal Nature without verifying the accuracy of the data, Riken said in April.

Obokata’s lawyer Hideo Miki declined to comment on Sasai’s death and said he has no plan to issue a statement. Wakayama didn’t immediately respond to an e-mail seeking comment.

Sasai, who graduated from Kyoto University in 1986, was a stem-cell biologist and is known for his work on coaxing stem cells to grow into different tissues, such as for brains and eyes. His studies led his colleague Masayo Takahashi at Riken to run the world’s first clinical trial in humans with stem cells made using the Nobel Prize-winning technique of Shinya Yamanaka.

To contact the reporters on this story: Kanoko Matsuyama in Tokyo at kmatsuyama2@bloomberg.net; Kiyotaka Matsuda in Tokyo at kmatsuda@bloomberg.net

To contact the editors responsible for this story: Anjali Cordeiro at acordeiro2@bloomberg.net Anjali Cordeiro, Frank Longid

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.